Cwm LLC Buys 9,841 Shares of AdaptHealth Corp. $AHCO

Cwm LLC grew its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 1,562.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,471 shares of the company’s stock after purchasing an additional 9,841 shares during the quarter. Cwm LLC’s holdings in AdaptHealth were worth $99,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Reinhart Partners LLC. increased its stake in shares of AdaptHealth by 1.1% in the 2nd quarter. Reinhart Partners LLC. now owns 7,312,626 shares of the company’s stock worth $68,958,000 after acquiring an additional 76,364 shares in the last quarter. Iron Triangle Partners LP bought a new position in shares of AdaptHealth in the 1st quarter worth about $17,496,000. Charles Schwab Investment Management Inc. increased its stake in shares of AdaptHealth by 14.3% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,301,652 shares of the company’s stock worth $14,110,000 after acquiring an additional 163,272 shares in the last quarter. New York State Common Retirement Fund increased its stake in shares of AdaptHealth by 10.3% in the 1st quarter. New York State Common Retirement Fund now owns 836,773 shares of the company’s stock worth $9,071,000 after acquiring an additional 78,211 shares in the last quarter. Finally, Foundry Partners LLC increased its stake in shares of AdaptHealth by 1.4% in the 1st quarter. Foundry Partners LLC now owns 815,036 shares of the company’s stock worth $8,835,000 after acquiring an additional 11,025 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Up 0.4%

NASDAQ:AHCO opened at $8.99 on Friday. The firm has a market cap of $1.22 billion, a P/E ratio of 16.65, a P/E/G ratio of 1.11 and a beta of 1.61. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.63. The firm has a 50-day simple moving average of $9.15 and a two-hundred day simple moving average of $9.02.

Analyst Ratings Changes

Several research analysts recently issued reports on AHCO shares. Zacks Research lowered shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Weiss Ratings reiterated a “sell (d+)” rating on shares of AdaptHealth in a research note on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of AdaptHealth from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 19th. Five analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, AdaptHealth currently has an average rating of “Hold” and a consensus target price of $13.40.

Insiders Place Their Bets

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of the firm’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director directly owned 50,045 shares in the company, valued at approximately $486,937.85. This trade represents a 14.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.55% of the company’s stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.